GO	[-6.23 -0.62]	[-0.62 -0.28]	[-0.28 -0.13]	[-0.13 -0.04]	[-0.04 0.00]	[0.00 0.00]	[0.00 0.09]	[0.09 0.19]	[0.19 0.33]	[0.33 0.70]	[0.70 5.50]
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-5.456	-2.144	-0.301	4.727	-0.906	-3.765	8.532	3.933	1.456	-4.522	-5.439
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-5.183	-4.267	-0.608	-0.791	-0.608	-5.183	0.791	11.499	6.527	0.791	-3.513
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-6.560	-2.464	0.342	1.436	-1.168	-3.437	6.479	8.872	1.436	-1.168	-6.539
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-3.761	-3.761	-1.608	-0.767	-0.580	-5.817	0.872	7.096	8.736	1.813	-3.747
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-5.496	-4.559	0.660	1.207	-1.162	-5.496	3.162	8.448	2.212	-0.722	-2.158
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-2.862	-0.935	2.484	15.209	1.029	-2.862	-0.252	-2.862	-1.363	-1.963	-1.956
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	2.012	-0.517	-3.061	-3.592	2.275	12.840	-4.203	-3.592	-1.260	-0.302	0.642
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-5.770	-2.833	-0.277	-1.045	-1.301	-4.039	1.983	1.481	11.769	1.259	-1.292
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-6.125	-1.211	-0.262	0.884	-0.262	-4.350	5.845	5.416	1.482	-0.776	-5.131
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-2.705	-1.095	-1.095	0.583	-1.335	-5.896	1.439	4.729	6.798	1.234	-5.034
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-5.335	-0.674	0.399	3.620	-0.674	-4.525	7.826	1.361	0.647	-0.525	-5.316
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-3.645	-1.784	2.275	0.261	1.287	-3.645	3.895	7.290	-0.761	-1.466	-5.094
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-3.061	-1.528	-0.659	3.160	0.507	-5.746	8.489	1.321	1.124	-0.829	-4.893
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-4.949	-2.228	0.319	1.325	-1.452	-4.949	2.744	5.993	2.744	0.319	-3.312
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.021	-0.572	8.022	5.315	0.468	-4.665	1.714	-0.442	-1.681	-1.681	-3.955
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-5.731	-2.331	1.076	1.507	0.889	-4.004	3.244	1.507	2.910	-0.634	-4.762
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-3.906	-0.422	2.291	1.533	1.315	-7.696	2.879	0.491	1.315	-0.701	-4.577
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-5.183	-0.608	1.649	0.974	-0.339	-2.914	7.529	1.914	-0.339	-0.791	-5.166
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-3.790	-2.982	-0.613	1.417	-0.613	-3.790	6.267	3.050	2.326	-1.432	-1.424
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.341	-3.460	-0.975	-0.581	-1.234	-4.194	2.581	4.010	4.412	2.271	-1.898
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-0.545	-1.691	-0.545	-0.415	-4.964	-5.928	-1.382	1.612	4.089	2.412	3.388
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-5.186	-2.634	0.440	1.941	-0.270	-3.132	2.495	4.946	0.866	0.564	-4.368
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-3.796	0.283	1.516	2.375	-0.442	-4.677	1.272	7.015	-1.016	-1.296	-3.080
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.442	0.736	-1.132	-2.411	-5.484	-0.914	-1.132	-1.386	0.468	4.523	8.555
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-2.264	-4.026	-1.278	0.771	-1.278	-2.264	1.255	5.355	4.831	0.412	-2.255
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-3.561	-1.508	0.309	3.528	-0.506	-3.561	1.559	4.229	2.589	-0.814	-4.857
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-1.926	-1.926	1.914	3.240	-0.539	-4.522	3.622	1.379	1.379	-2.962	-2.949
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	1.191	-0.405	-1.669	-2.922	2.160	9.756	-3.483	-1.669	-2.026	-0.405	0.826
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-4.059	-2.043	-0.388	-0.538	-1.609	-2.043	0.990	6.222	5.227	0.610	-2.033
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-3.939	-0.714	0.479	1.508	-1.659	-3.939	-0.327	2.542	2.542	4.197	-3.922
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-4.236	-1.045	0.386	2.521	-0.672	-4.947	2.521	5.277	0.926	-0.528	-2.610
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-2.770	-3.776	0.693	-0.391	-0.812	-2.770	2.119	4.279	2.901	0.504	-2.761
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-3.359	-1.832	-1.173	-0.541	-1.474	-4.988	0.884	2.382	5.924	2.081	0.426
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-2.239	-2.239	2.076	7.678	0.435	-1.431	1.652	-0.578	-0.921	-1.431	-2.233
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-2.217	-1.117	1.724	-0.523	0.412	-3.153	3.408	5.583	-1.580	-0.341	-3.144
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-5.400	-0.813	1.091	2.841	1.091	-2.188	2.168	3.209	-0.610	-2.188	-2.722
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-6.758	-0.302	-0.302	0.944	-0.302	-6.758	3.486	1.535	0.781	1.321	-1.019
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-6.283	-1.044	0.987	1.177	-1.044	-4.490	1.610	1.853	2.391	1.610	-2.268
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-3.790	-1.432	0.735	2.326	0.735	-2.982	0.936	1.417	3.447	-0.829	-4.886
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-6.151	-1.153	0.319	0.568	-0.528	-2.228	4.227	3.087	2.420	-0.697	-2.217
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-3.122	-1.957	0.500	2.496	-0.905	-2.477	4.498	1.563	2.161	-1.533	-2.466
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-3.183	-1.407	-1.051	-0.771	-1.051	-2.432	1.665	6.012	3.983	0.346	-1.045
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-4.203	-0.659	3.826	0.781	-0.517	-4.911	4.551	0.781	0.301	-0.302	-1.826
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-1.447	-1.747	-0.473	-1.186	-1.747	-3.468	0.334	3.321	7.328	1.635	-0.763
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	0.856	2.468	-0.958	-1.836	-1.836	-0.958	-0.958	-3.485	-0.958	1.726	5.997
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.606	-0.854	-0.606	-1.592	-3.859	-0.279	-0.854	-1.592	0.472	4.632	6.296
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-2.228	-0.904	1.325	2.116	0.725	-3.326	2.420	1.568	1.103	-1.807	-4.933
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	-3.319	-0.397	2.693	3.136	0.353	-2.363	0.724	2.693	-1.225	-1.707	-2.355
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-3.102	-1.807	-0.262	-0.468	-1.487	-3.102	0.577	5.416	2.835	2.242	-1.202
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-2.658	-1.966	-0.351	-0.522	-1.053	-2.658	4.510	3.079	2.263	0.557	-1.958
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.612	-2.253	-1.612	2.875	-0.355	-2.253	4.904	2.444	0.578	-1.612	-1.139
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-4.775	-1.034	1.007	3.207	-0.405	-2.878	1.801	1.801	0.795	-0.405	-2.867
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-2.197	-2.197	-0.642	0.612	-0.642	-3.943	0.816	1.942	6.085	0.612	-1.220
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-2.224	-0.957	0.276	0.276	-0.581	-4.632	1.870	5.842	1.615	0.492	-2.673
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	1.851	-1.048	-0.636	-0.482	-3.595	-2.976	-1.318	-1.048	0.756	2.745	5.484
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-2.903	-1.999	-0.264	0.519	-0.422	-2.903	0.737	0.737	6.229	0.737	-1.387
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	7.761	0.967	-2.072	-0.983	-0.744	1.440	-1.277	-2.605	-2.072	0.445	0.599
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-3.236	-0.919	0.692	0.692	-0.739	-3.779	2.932	5.814	0.442	-0.739	-1.120
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	-3.157	-1.985	0.486	1.272	-1.209	-3.157	5.370	0.644	2.122	-0.694	-0.505
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-2.523	-0.570	1.803	1.803	-0.926	-7.278	2.639	0.617	0.617	0.276	-0.564
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-3.873	-0.687	0.783	1.338	0.293	-4.560	1.559	2.918	0.389	1.135	-2.760
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	-3.617	-0.703	0.451	2.577	-0.384	-3.617	1.406	3.289	0.595	0.330	-2.917
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-3.610	-0.731	-0.505	1.023	2.312	-2.621	2.712	1.943	0.576	-1.420	-1.926
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	-1.490	-1.490	0.965	-0.328	-0.581	-6.818	0.276	0.630	1.162	4.971	0.279
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	0.496	0.766	-0.528	1.104	-3.090	-3.623	-1.278	-2.217	0.293	2.244	4.908
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-1.362	0.257	1.687	4.455	-1.074	-4.793	0.985	1.687	-0.638	-0.350	-2.594
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-3.906	-1.637	-0.548	-0.422	-0.701	-2.803	1.769	4.626	2.021	1.315	-0.875
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-2.319	-1.815	-0.598	0.959	-0.301	-3.752	1.190	3.925	3.102	-0.430	-1.400
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-2.399	-0.373	0.896	2.381	-0.752	-3.145	1.702	2.028	0.507	-0.250	-4.181
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-2.637	-0.652	-0.258	-0.490	-1.384	-4.832	2.538	3.597	2.224	-0.490	0.352
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-2.194	-1.310	-0.381	1.303	-1.310	-3.599	1.576	5.627	1.057	-0.537	-0.732
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.663	-0.663	1.939	8.013	-0.663	-0.663	-0.663	-0.663	-0.661
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-4.367	0.361	2.370	2.056	0.361	-3.511	1.492	1.245	-0.352	-0.656	-2.266
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-2.760	-2.760	-0.586	0.341	-0.739	-3.779	3.907	2.092	1.393	1.193	-0.261
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-2.132	-0.703	1.644	1.363	0.511	-4.609	1.363	3.023	0.251	-0.950	-2.123
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-3.145	-1.029	0.359	2.760	-0.537	-2.399	5.555	1.136	-0.752	-0.537	-1.023
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-1.659	-0.327	-0.898	-0.432	-2.385	-3.345	-0.714	-0.327	2.258	3.157	4.220
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-2.172	-2.667	0.457	1.626	0.457	-2.667	1.897	3.934	0.457	-0.267	-2.655
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.907	-1.907	-1.158	-0.411	-0.702	-1.158	-0.411	3.193	5.116	0.920	-0.699
GREENBAUM_E2A_TARGETS_UP GREENBAUM_E2A_TARGETS_UP	-1.367	-0.733	-1.367	-1.367	-0.733	-1.367	2.092	2.092	2.669	1.130	-1.364
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-2.065	0.349	-0.258	-0.812	-3.776	-2.065	0.504	3.794	2.496	1.168	-0.807
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-5.298	0.987	-0.392	0.662	-1.901	-3.223	-0.660	1.610	0.815	2.685	0.996
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-3.107	-0.360	-0.360	2.071	-0.733	-2.365	4.602	1.164	0.921	-0.733	-2.356
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-1.975	-0.351	2.092	1.009	-0.586	-4.403	3.567	1.843	0.442	-1.373	-1.962
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-2.073	-0.810	-0.810	3.991	-0.810	-2.073	1.095	1.095	1.877	-0.285	-2.067
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-1.431	-0.921	-0.921	-0.921	-0.578	-2.239	0.435	3.602	4.817	0.664	-1.426
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-0.961	-1.393	-0.647	0.737	-0.961	-1.999	3.353	4.988	0.737	-0.961	-1.992
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-2.101	-1.299	1.679	0.749	-1.661	-4.136	2.982	1.971	0.432	0.749	-1.292
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-2.277	-1.241	0.260	4.451	0.260	-2.277	1.560	1.560	0.601	0.355	-3.920
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-3.194	-0.355	-0.355	0.578	-3.194	-2.253	1.055	3.338	1.680	0.396	-0.352
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-2.820	-0.390	-0.606	1.375	-1.927	-1.332	2.119	2.546	2.119	-0.606	-1.920
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	0.254	0.500	-0.905	-1.186	-1.957	-2.477	-1.957	-0.354	0.500	4.055	4.518
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-1.308	-1.803	0.313	2.130	-0.289	-1.308	2.946	3.880	-0.652	-2.473	-1.302
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-2.657	-0.737	-0.319	1.184	-0.430	-4.595	1.404	4.615	0.805	0.384	-1.458
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.071	-2.671	-1.595	1.163	-0.479	-0.668	3.130	3.130	1.426	-0.334	-2.061
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-0.733	0.371	-1.006	-2.365	-0.521	-0.733	-2.365	-0.360	0.371	1.438	8.003
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-1.635	0.321	-1.277	-2.072	-1.635	-0.400	-1.277	-0.552	4.691	1.191	3.838
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	0.633	-0.867	-1.327	0.293	-4.560	-1.615	-0.687	-0.310	0.502	4.678	2.936
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-2.745	-0.608	0.260	0.355	-0.992	-3.936	1.118	4.061	1.810	1.118	-1.524
MARTINEZ_RESPONSE_TO_TRABECTEDIN MARTINEZ_RESPONSE_TO_TRABECTEDIN	0.317	2.847	2.847	2.847	-0.810	-1.294	-1.294	-2.073	-0.810	-1.294	-0.806
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-2.509	-1.209	0.828	3.577	-0.924	-3.157	1.272	2.452	0.644	-0.510	-1.550
ZHU_CMV_24_HR_UP ZHU_CMV_24_HR_UP	-2.436	-1.771	-0.427	-0.427	-1.280	-1.771	0.484	5.014	3.008	0.679	-0.629
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	1.169	0.392	-1.691	-2.051	-0.704	3.033	-1.382	-2.952	-0.893	1.381	3.388
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-2.821	0.292	2.013	-0.957	-1.520	-3.426	3.306	0.292	0.845	2.013	-0.950
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-1.452	-0.697	1.568	2.744	-0.528	-4.049	1.325	1.325	0.903	-0.528	-3.312
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-1.933	-1.420	0.267	1.023	0.576	-2.621	1.943	2.712	1.604	-1.029	-2.612
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-0.486	-1.281	-0.269	2.014	-2.331	-3.355	5.159	0.574	0.889	0.336	-1.568
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	0.416	0.910	0.416	-1.466	-0.949	0.910	-1.466	-2.280	-0.365	-1.466	6.061
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-3.748	-0.447	-0.447	1.416	-1.354	-3.207	2.969	2.969	-0.447	0.859	-0.442
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-2.256	-0.567	-0.405	1.801	-0.567	-4.775	2.116	1.801	1.510	-0.405	-1.027
MATTIOLI_MGUS_VS_PCL MATTIOLI_MGUS_VS_PCL	-4.097	-2.072	0.321	0.445	2.008	0.967	1.440	1.712	0.445	-0.744	-3.250
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-3.485	-1.336	-0.301	0.636	-0.958	-1.336	0.636	2.886	3.807	0.301	-1.329
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.851	-0.490	-0.652	0.469	-0.490	-4.832	-2.145	3.225	2.224	1.930	-0.356
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-2.696	-1.077	0.376	0.539	1.231	-1.999	0.736	3.934	1.528	-1.999	-1.470
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-2.696	-2.696	-0.364	-0.364	0.246	-1.077	0.736	5.504	1.231	0.736	-1.470
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-2.603	-0.451	0.976	1.491	-0.634	-3.372	1.491	2.840	0.976	-0.869	-2.000
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	0.914	-1.114	-0.714	-0.898	-1.997	-2.831	-0.560	-0.432	0.277	4.574	3.857
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	2.312	-0.505	0.267	-2.621	0.267	3.596	-2.621	-1.420	-0.505	-1.029	1.953
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	3.240	0.580	-1.535	-1.926	-0.539	1.914	-0.719	-2.395	-2.395	0.745	2.228
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-2.280	-0.949	0.245	2.473	1.232	-2.280	-0.600	2.015	1.601	-0.949	-1.461
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-3.111	-1.549	-0.327	0.276	-0.753	-3.111	1.769	1.119	2.147	1.426	-0.325
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	-1.948	0.597	-0.431	0.597	0.597	-1.191	4.987	1.225	-1.191	-1.191	-1.943
TANG_SENESCENCE_TP53_TARGETS_DN TANG_SENESCENCE_TP53_TARGETS_DN	-0.977	-0.622	-0.382	-1.501	-1.501	-1.501	-0.622	4.598	2.895	1.551	-0.973
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-4.246	-1.424	0.617	0.768	-0.926	-2.523	2.953	0.938	0.938	1.803	-0.918
LI_AMPLIFIED_IN_LUNG_CANCER LI_AMPLIFIED_IN_LUNG_CANCER	-3.808	-0.660	-1.044	0.987	0.526	-1.288	1.610	4.783	0.309	-2.281	0.532
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-2.863	-0.510	0.423	0.853	-1.063	-4.073	0.690	2.520	3.502	-0.385	-0.655
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	-1.252	1.575	1.097	3.519	-1.583	-2.455	0.414	1.575	0.301	-0.977	-3.015
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-1.966	-1.448	-0.351	3.079	-0.351	-2.658	1.264	2.263	1.264	-0.522	-1.958
SMIRNOV_RESPONSE_TO_IR_6HR_DN SMIRNOV_RESPONSE_TO_IR_6HR_DN	-1.732	-0.393	-1.013	-0.272	-0.756	-2.843	-0.393	1.274	3.675	3.675	-1.326
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-2.363	-0.865	-0.397	-0.865	-0.596	-3.319	-0.397	0.965	1.555	4.109	0.971
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-1.595	-0.909	-0.668	-0.334	-0.668	-2.671	0.542	2.739	3.544	1.715	-2.061
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-1.907	-0.702	0.389	5.840	-0.228	-1.907	-0.228	0.625	0.625	-0.411	-1.901
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-1.781	-0.886	-0.275	2.786	-1.133	-3.293	1.351	1.597	1.864	0.445	-2.189
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	-2.446	-0.691	-0.691	-1.606	0.346	-2.446	1.791	1.791	1.791	1.411	-0.687
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-2.994	-1.559	1.880	3.570	0.727	-1.559	1.120	0.727	-1.559	0.426	-1.550
ZHU_CMV_ALL_UP ZHU_CMV_ALL_UP	-1.540	-2.009	-0.634	-0.869	-1.167	-2.009	0.576	4.582	2.464	1.220	-0.309
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-2.031	-1.259	-0.271	0.546	-0.271	-2.031	2.929	1.938	1.137	-0.271	-2.026
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-0.728	-1.193	3.353	1.769	-2.790	-2.790	0.864	1.511	0.864	-0.728	-1.185
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-0.851	-1.384	0.612	2.538	-0.258	-2.637	2.872	1.173	-0.258	-0.258	-3.926
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	1.679	1.410	0.578	-1.661	-2.101	-0.412	-3.298	-0.566	-1.299	0.945	3.379
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-2.903	-0.422	1.297	3.867	-0.422	-2.903	1.636	-0.264	-0.264	-0.647	-0.643
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	-1.384	1.173	0.348	0.612	-0.490	-3.940	5.268	0.964	-0.490	-1.731	-0.646
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-3.226	-0.652	0.612	0.612	-1.093	-4.832	1.930	1.930	0.777	0.348	0.618
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-2.654	-1.783	0.274	0.274	-0.527	-1.211	1.546	4.395	1.546	-0.810	-0.806
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-1.431	-0.921	3.053	2.543	1.652	-1.431	0.664	-0.578	-0.578	-0.921	-2.233
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-1.963	-2.862	-0.626	-0.252	-0.406	-1.363	0.539	4.503	2.065	0.539	-0.622
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-2.145	-1.093	-1.384	-1.384	-0.490	0.612	-1.093	-0.851	1.404	3.597	3.616
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.893	-0.332	-2.197	1.319	0.272	-2.197	2.616	1.319	0.980	-0.332	-2.191
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-2.982	-1.099	-0.443	1.417	-1.099	-2.351	1.163	4.305	0.936	0.413	-0.823
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-2.903	-1.393	0.519	0.342	-0.422	-2.903	1.636	1.297	2.872	-0.422	-0.419
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	1.765	0.311	-0.792	-1.383	0.439	5.905	-1.383	-2.913	-0.792	-0.582	0.598
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-2.529	-0.738	1.004	1.325	-0.470	-2.529	1.325	1.004	2.094	-0.738	-1.671
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-2.621	-1.029	0.576	0.782	0.782	-2.621	1.604	3.596	0.404	-1.420	-1.023
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-1.367	-1.367	0.754	2.092	0.231	-1.367	2.669	0.754	0.231	-1.367	-1.364
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-1.706	-0.638	0.482	0.985	-0.350	-1.706	1.963	5.333	-0.638	-0.638	-2.594
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-1.416	-1.416	0.504	-1.104	-2.247	-1.792	1.522	1.796	3.492	1.271	-0.842
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	0.587	-1.536	-1.006	-1.006	-1.536	-2.363	-0.645	1.900	0.845	0.845	3.352
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-1.027	-2.331	0.445	-0.366	-1.578	-2.804	1.282	4.744	1.507	0.336	-0.361
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.302	-0.374	0.238	4.691	0.388	-1.302	1.416	1.096	-0.586	-1.302	-2.771
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-3.360	-0.266	-0.266	2.635	-0.266	-0.614	1.516	2.230	-0.266	-1.253	-2.391
THILLAINADESAN_ZNF217_TARGETS_UP THILLAINADESAN_ZNF217_TARGETS_UP	-0.318	-0.991	-1.699	0.501	-0.318	-1.699	3.082	0.285	3.700	-0.991	-0.987
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-2.200	-1.133	0.923	3.497	-0.381	-2.698	1.864	0.742	1.126	-1.429	-1.125
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	0.539	-1.477	-0.771	-1.477	-2.696	-1.477	-0.538	2.602	2.602	1.856	0.379
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-1.929	1.439	1.660	1.234	0.270	-5.896	0.583	0.875	0.721	-0.889	-1.086
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	0.429	0.849	0.326	-1.249	-3.162	-3.742	0.551	-0.806	0.691	1.025	3.776
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	-1.901	-1.901	-0.261	0.457	-1.261	-3.323	1.781	1.097	1.097	3.287	-0.470
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-1.901	-0.489	1.052	2.768	-2.584	-1.901	1.052	1.331	0.806	0.278	-1.893
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.057	-1.057	0.453	-1.782	-1.057	-1.782	1.861	1.423	1.423	1.861	-1.053
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-2.571	-1.152	0.478	2.037	-0.301	-2.571	0.970	1.284	1.284	0.301	-1.706
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-1.990	-0.755	0.571	2.001	-0.256	-1.225	2.001	2.485	-0.755	-0.755	-1.984
LUI_TARGETS_OF_PAX8_PPARG_FUSION LUI_TARGETS_OF_PAX8_PPARG_FUSION	-1.409	-1.409	0.427	1.512	1.512	-0.765	3.191	0.216	-0.407	-1.409	-1.405
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.884	0.421	-0.402	-2.256	-3.359	-0.402	-2.256	-0.402	1.300	1.539	3.059
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.721	0.721	-1.612	-0.562	-2.291	0.583	-1.095	-0.889	-1.929	3.006	3.673
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	-1.654	-0.351	-0.264	1.610	-1.654	-3.779	2.356	3.242	0.341	-0.351	-0.732
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-1.383	-0.582	0.593	0.775	0.983	-2.288	3.559	1.218	-0.291	-0.582	-3.702
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-1.403	0.416	-0.693	0.543	-2.117	-3.731	0.416	-0.889	2.282	1.996	2.010
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-2.253	-0.541	0.396	2.046	0.253	-2.253	4.353	0.798	-0.355	-1.144	-1.139
ZHANG_INTERFERON_RESPONSE ZHANG_INTERFERON_RESPONSE	-0.994	-0.994	-0.994	-0.994	-0.994	0.426	-0.994	-0.204	0.772	3.048	2.363
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	-1.741	-1.024	-0.336	0.749	-1.741	-1.024	1.083	4.242	1.083	-0.336	-1.020
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-2.455	-2.012	1.352	0.934	-0.482	-3.595	0.934	1.851	1.591	0.463	-0.816
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	-0.261	-0.798	-0.475	-1.261	-2.774	-2.774	-0.261	0.738	1.534	4.397	0.916
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-1.899	0.330	-1.511	-0.274	-0.703	-3.617	1.169	3.289	1.666	0.954	-0.697
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-1.980	-1.980	-0.418	0.551	-1.583	-1.980	2.454	2.454	0.892	1.575	-0.745
NAKAMURA_CANCER_MICROENVIRONMENT_DN NAKAMURA_CANCER_MICROENVIRONMENT_DN	-1.124	-0.676	-0.676	1.736	-1.124	-1.865	-0.676	2.204	3.288	0.409	-1.120
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.468	0.721	0.577	-0.262	-1.807	-3.102	-1.487	-0.776	-0.354	1.971	4.626
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-1.406	-1.113	0.943	-0.371	-0.267	-4.871	0.597	2.498	1.377	1.150	-1.105
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-2.247	-0.342	0.264	5.691	0.660	-2.247	0.840	-0.473	0.660	-0.473	-1.783
VALK_AML_CLUSTER_16 VALK_AML_CLUSTER_16	-0.610	3.824	-0.300	1.365	0.302	-1.202	-1.202	1.365	-0.610	-1.202	-1.198
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-1.868	-0.473	0.435	-0.473	-1.364	-3.527	0.435	0.615	0.831	4.232	0.438
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-3.334	-0.617	0.783	0.593	-0.438	-3.334	2.156	0.301	2.156	0.593	-0.843
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-2.145	0.469	1.404	1.173	-0.490	-4.832	-0.490	2.224	0.777	0.469	-1.086
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-1.362	-2.156	-0.535	1.364	-0.535	-2.156	0.720	1.364	2.690	0.476	-0.861
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	-2.576	0.265	-0.465	-0.623	-0.623	-3.868	1.998	1.459	2.619	0.643	-0.461
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-2.277	-1.241	0.926	2.365	-0.464	-2.745	2.365	0.926	0.754	0.260	-1.866
MOSERLE_IFNA_RESPONSE MOSERLE_IFNA_RESPONSE	-1.326	-1.326	-0.363	-0.702	-0.702	-1.326	0.247	-0.363	0.480	1.647	4.920
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-0.506	0.962	0.649	-1.011	-2.167	-3.561	-0.814	-0.506	0.519	2.307	3.219
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-1.006	-0.733	-1.006	1.740	1.438	-3.107	2.429	1.438	0.371	-1.798	-0.728
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-1.567	-0.889	0.559	-0.889	-0.889	-4.484	0.559	1.191	1.191	1.752	1.199
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-2.031	-0.782	-0.271	1.938	0.814	-2.031	0.546	1.137	1.938	-1.259	-1.255
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	1.638	-0.369	-1.643	-1.643	-0.369	0.381	-0.820	-1.643	-1.171	3.755	2.006
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-2.571	-0.301	0.301	1.284	-0.762	-2.571	1.640	1.284	0.970	-1.712	0.481
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-0.860	-0.359	0.250	6.040	0.250	-1.855	-0.860	0.846	0.846	-0.860	-1.848
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-2.152	-0.345	1.287	3.895	-0.345	-3.645	0.590	0.590	0.901	-1.192	-0.754
LUI_THYROID_CANCER_CLUSTER_3 LUI_THYROID_CANCER_CLUSTER_3	-1.160	-1.160	0.607	1.962	1.432	-0.580	2.564	-0.580	-0.580	-1.160	-1.157
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	1.205	1.546	-1.211	-0.527	-0.810	-0.810	-1.211	-1.211	-0.810	-0.329	5.637
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.550	-1.119	-1.119	-0.260	-1.119	-1.119	-0.260	1.032	4.126	1.503	-0.548
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.590	0.901	-2.152	-0.595	-0.959	-1.466	-0.761	-1.466	0.353	1.287	5.502
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	0.433	2.420	0.319	-0.528	-0.392	-4.049	-0.392	-1.153	-0.528	4.227	-0.691
PLASARI_TGFB1_TARGETS_10HR_UP PLASARI_TGFB1_TARGETS_10HR_UP	0.496	-0.672	-0.844	-1.278	-3.090	-1.278	-0.528	-0.408	1.510	2.813	3.140
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-2.156	-0.535	2.203	2.690	0.476	-2.156	1.017	-0.535	-0.865	0.286	-0.861
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	0.945	-1.003	0.432	0.578	-2.101	-3.298	-1.003	-0.761	0.432	2.286	2.637
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	-2.188	0.395	-0.813	2.841	-1.369	-3.404	0.881	-0.610	0.695	1.583	0.701
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-1.756	0.457	0.597	3.547	-0.503	-3.259	2.187	0.338	0.457	-1.406	-0.862
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-3.060	-0.996	0.291	1.074	-0.767	-3.060	0.291	-0.430	1.298	2.414	1.556
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-1.253	-0.412	0.502	4.031	-0.888	-3.360	1.209	0.937	0.339	-0.614	-0.883
HUANG_DASATINIB_SENSITIVITY_UP HUANG_DASATINIB_SENSITIVITY_UP	-1.225	-0.397	-0.865	-0.865	-1.707	-2.363	-0.255	0.353	1.902	2.693	2.292
BERNARD_PPAPDC1B_TARGETS_UP BERNARD_PPAPDC1B_TARGETS_UP	-1.533	1.332	-0.477	2.876	-0.477	-1.533	1.788	0.359	-0.250	-1.533	-0.857
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	0.770	-0.767	-0.337	-0.767	-0.452	-0.594	-0.767	-2.715	-0.767	1.354	6.261
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	-3.523	-0.508	-0.357	0.682	0.367	-1.649	3.428	2.284	0.251	-0.357	-1.254
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-2.118	0.998	0.425	-0.484	-1.770	-2.517	1.185	1.389	0.998	2.372	-1.758
RIEGE_DELTANP63_DIRECT_TARGETS_UP RIEGE_DELTANP63_DIRECT_TARGETS_UP	-1.231	-0.735	0.310	-0.735	-0.959	-3.689	0.565	1.880	1.120	3.570	-0.548
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-1.241	-1.241	0.876	1.876	-0.546	-1.819	1.876	1.502	0.876	-1.241	-1.813
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-1.901	-0.711	0.595	3.665	-2.584	-1.005	0.806	1.331	0.278	0.595	-1.385
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	-1.188	0.595	1.666	-0.703	-1.511	-2.929	-0.526	-0.703	0.595	4.504	0.456
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	0.477	1.730	0.351	-0.671	-1.463	1.730	2.019	0.998	-1.463	-2.295
TAKAO_RESPONSE_TO_UVB_RADIATION_DN TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-2.298	-0.962	0.558	2.159	0.398	-3.032	1.819	1.507	-0.336	0.269	-1.296
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-1.783	-1.783	-0.329	0.651	-0.527	-1.211	3.302	2.808	0.440	-0.329	-1.206
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	0.435	0.944	-1.431	-0.578	-0.578	-1.431	-1.431	0.258	0.258	-0.578	6.195
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-1.171	-0.369	-0.820	-0.820	-1.171	-2.290	0.772	-0.369	0.243	3.269	3.282
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	-1.865	-1.124	-0.392	-0.392	-0.676	-0.676	0.958	5.988	0.654	-0.392	-0.673
SU_LIVER SU_LIVER	3.257	-0.247	-0.668	-2.405	-0.416	2.747	-0.247	-1.035	-1.571	-0.416	0.567
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-1.699	-1.699	0.285	0.285	-0.318	-0.574	3.082	0.501	1.997	-0.318	-1.695
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-2.009	-1.167	0.576	0.976	1.220	-2.603	0.762	2.464	0.762	-0.451	-2.000
BROWNE_INTERFERON_RESPONSIVE_GENES BROWNE_INTERFERON_RESPONSIVE_GENES	-1.302	0.388	-0.374	-0.885	-1.891	-1.302	-0.374	-0.586	0.581	5.293	1.423
MILI_PSEUDOPODIA MILI_PSEUDOPODIA	-1.259	-0.472	1.512	2.411	-2.031	-2.031	0.334	1.137	-0.782	0.814	-0.469
HU_GENOTOXIC_DAMAGE_4HR HU_GENOTOXIC_DAMAGE_4HR	-1.492	-0.453	-0.453	-0.453	-0.453	-1.492	0.646	0.646	5.856	-0.234	-0.825
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-2.395	-0.396	0.745	0.438	-0.719	-2.395	3.622	2.536	-0.719	-0.396	-0.534
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	-0.461	0.860	-1.084	-1.392	-0.831	-1.766	-0.831	0.273	0.860	6.263	0.276
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-2.288	-0.418	1.479	2.076	-0.792	-2.913	0.439	0.775	2.076	-0.582	-1.049
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	-2.831	-1.659	0.914	0.479	-0.432	-1.114	4.574	0.479	0.914	0.370	-1.357
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.521	-0.293	-0.395	-1.646	-0.676	-2.001	-0.395	-1.081	0.675	1.431	5.869
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-1.393	-0.961	0.519	0.997	-1.393	-1.393	2.872	1.297	1.297	-0.422	-1.992
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	0.557	0.995	-0.751	-1.448	-0.351	0.256	-2.658	-1.966	0.390	0.759	4.022
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.729	-0.729	-1.948	-0.431	0.883	-1.191	0.597	2.066	2.066	0.597	-1.943
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.086	0.870	0.679	-1.164	-0.661	-0.885	-2.445	-2.445	0.515	0.376	3.707
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	-0.910	-0.606	0.790	1.375	-0.910	-1.927	3.008	1.728	-0.240	-0.910	-1.920
LIN_APC_TARGETS LIN_APC_TARGETS	-1.424	-1.424	1.259	0.966	-2.035	-1.424	0.712	3.280	0.499	0.328	-0.981
ZHAN_MULTIPLE_MYELOMA_UP ZHAN_MULTIPLE_MYELOMA_UP	-1.783	-0.810	-0.810	3.302	-0.810	-1.211	-0.329	3.832	0.440	-0.527	-0.327
BROWNE_HCMV_INFECTION_12HR_UP BROWNE_HCMV_INFECTION_12HR_UP	-2.774	0.355	0.664	1.333	-0.522	-2.774	-0.720	2.594	-0.369	1.610	-0.715
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-1.739	-0.888	-0.412	-0.412	-0.888	-0.614	1.209	2.635	3.537	-0.412	-1.732
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	-1.865	-1.124	-1.124	-1.124	-0.676	-0.392	0.226	0.226	1.320	1.736	3.298
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	-0.280	-0.280	0.978	5.629	-0.280	-1.160	-0.280	-1.160	-1.160	-0.280	-0.577
CHOI_ATL_STAGE_PREDICTOR CHOI_ATL_STAGE_PREDICTOR	-1.090	-0.650	-0.373	3.385	-1.090	-1.090	0.684	2.277	0.430	-0.373	-1.819
HONMA_DOCETAXEL_RESISTANCE HONMA_DOCETAXEL_RESISTANCE	-1.450	-1.450	-1.450	2.478	0.680	-0.796	1.449	1.030	0.403	-0.430	-0.793
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-1.360	0.439	-0.856	0.328	-1.684	-2.065	-1.086	0.439	0.895	4.486	1.312
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.909	-2.071	-0.668	0.721	-0.909	-2.671	2.031	2.031	1.426	0.721	-0.663
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-2.239	0.944	0.944	1.652	-0.348	-1.431	1.274	0.435	0.435	-0.921	-2.233
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-0.411	0.629	1.053	0.827	-1.918	-2.500	-0.585	2.244	0.323	1.309	-2.491
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-2.031	0.334	-0.271	-0.472	-1.259	-2.031	-0.271	-0.472	1.512	1.512	2.419
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-0.691	-0.434	-1.606	-1.064	-0.260	0.784	-1.606	-1.064	0.346	2.213	3.729
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	0.599	0.934	-0.260	1.352	-4.339	-2.976	-0.823	0.347	0.463	1.352	0.605
WANG_TARGETS_OF_MLL_CBP_FUSION_DN WANG_TARGETS_OF_MLL_CBP_FUSION_DN	-1.865	-0.676	0.409	1.320	-0.676	-1.124	3.288	-0.676	1.736	-0.392	-1.120
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-2.256	-1.358	-0.774	0.795	0.795	-1.358	1.801	2.820	1.007	-1.358	-0.562
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-2.280	-0.365	-0.365	2.015	-0.600	-2.280	0.910	0.416	-0.600	2.473	-0.362
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.027	-0.269	0.336	-0.486	-1.578	-4.004	1.752	0.574	0.889	2.910	-0.481
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-2.322	0.233	-0.622	0.612	-0.977	-1.501	0.612	0.877	3.993	0.397	-0.973
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-1.227	-0.642	2.681	1.052	-0.301	-2.919	0.612	1.318	-0.447	0.612	-2.189
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	-0.320	-0.320	1.301	-0.320	-0.640	2.991	1.796	-0.640	-1.243	-1.240
SESTO_RESPONSE_TO_UV_C2 SESTO_RESPONSE_TO_UV_C2	-2.197	0.455	-0.556	0.691	-1.397	-2.197	2.139	1.706	-0.332	0.455	0.274
EPPERT_HSC_R EPPERT_HSC_R	0.321	0.768	3.031	0.967	-0.983	-4.097	0.445	-0.552	-0.983	0.967	-0.976
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-3.258	-0.810	-0.411	0.629	0.461	-3.258	1.593	1.309	1.053	0.461	-0.277
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	0.547	2.520	-0.662	-1.976	-0.662	-1.321	-1.623	-0.845	-0.285	1.236	3.176
TIAN_TNF_SIGNALING_NOT_VIA_NFKB TIAN_TNF_SIGNALING_NOT_VIA_NFKB	-0.406	-0.911	0.873	-0.406	-0.406	-0.911	-0.911	0.217	-0.406	6.029	-0.404
LUI_THYROID_CANCER_PAX8_PPARG_DN LUI_THYROID_CANCER_PAX8_PPARG_DN	-1.907	-1.158	0.920	1.677	1.271	-1.158	1.677	-0.411	0.625	-1.158	-1.153
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.934	1.439	0.467	-0.289	-1.308	-3.444	-0.934	0.467	0.657	-0.289	2.959
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	-1.986	-0.348	1.620	5.523	-0.470	-1.297	0.475	-1.297	-0.348	-0.470	-0.465
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	-0.252	-0.252	-1.963	-0.626	-0.626	-2.862	0.357	0.357	1.029	3.950	0.360
FAELT_B_CLL_WITH_VH3_21_UP FAELT_B_CLL_WITH_VH3_21_UP	-1.124	-0.676	0.958	1.320	-1.865	-0.676	0.409	3.898	0.226	-1.124	-0.673
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	0.870	0.870	-0.343	-2.445	-0.661	-0.343	-1.508	-1.928	0.515	0.515	4.135
SHEPARD_CRASH_AND_BURN_MUTANT_DN SHEPARD_CRASH_AND_BURN_MUTANT_DN	-1.792	-2.143	-0.380	-1.223	-0.495	-0.995	0.980	0.813	2.924	2.624	-0.489
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-1.202	-0.300	-0.610	-1.202	-1.202	-0.300	-0.300	-0.610	0.928	3.824	1.369
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-1.367	-0.733	-0.385	0.231	-0.733	-1.367	0.453	2.092	1.577	1.577	-1.364
FURUKAWA_DUSP6_TARGETS_PCI35_UP FURUKAWA_DUSP6_TARGETS_PCI35_UP	1.187	-0.471	-0.471	-0.710	-1.038	0.463	-2.107	-1.038	-0.471	5.285	0.466
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	-1.675	-0.383	0.994	-0.577	-1.198	-3.277	0.748	2.753	0.538	0.538	0.370
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-1.659	0.277	0.751	0.479	-1.367	-4.630	0.914	1.992	1.094	0.479	-0.322
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.818	0.522	-1.362	-2.440	-0.301	1.191	-2.440	-1.362	0.522	1.406	2.175
WOOD_EBV_EBNA1_TARGETS_UP WOOD_EBV_EBNA1_TARGETS_UP	-2.705	0.701	-0.493	0.261	-0.346	-3.485	0.261	2.690	0.380	1.394	0.263
BOWIE_RESPONSE_TO_TAMOXIFEN BOWIE_RESPONSE_TO_TAMOXIFEN	-0.746	-0.746	-0.746	-0.746	-0.298	-0.746	-0.746	0.304	0.655	1.713	3.190
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-1.787	0.439	0.593	3.154	-0.582	-1.383	0.983	1.765	-0.291	-1.383	-1.779
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	-1.119	-0.550	0.644	-0.260	-1.119	-1.119	-1.119	-0.260	1.032	0.644	3.376
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-0.753	-2.180	-0.506	-0.327	-0.506	-1.091	2.147	3.004	1.119	0.428	-1.542
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-2.696	-0.538	0.376	1.856	2.214	-0.771	0.539	1.231	0.246	-1.077	-1.991
LEE_LIVER_CANCER_SURVIVAL_UP LEE_LIVER_CANCER_SURVIVAL_UP	0.914	2.258	-0.327	-0.898	-0.714	-1.114	-0.432	-0.898	-2.831	0.479	3.509
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	0.937	-0.412	-1.739	-1.253	0.701	-0.614	-1.253	-1.253	0.339	0.701	4.571
YAGI_AML_WITH_T_9_11_TRANSLOCATION YAGI_AML_WITH_T_9_11_TRANSLOCATION	-2.766	0.384	0.860	2.795	-1.392	-2.218	1.298	0.677	0.273	0.384	-0.825
RADAEVA_RESPONSE_TO_IFNA1_UP RADAEVA_RESPONSE_TO_IFNA1_UP	-1.948	-1.191	-0.729	0.597	-0.431	-1.948	-0.431	0.883	0.883	2.066	1.230
CHESLER_BRAIN_QTL_CIS CHESLER_BRAIN_QTL_CIS	-1.486	-1.038	0.301	5.895	-0.710	-1.486	-0.710	0.301	0.664	0.463	-0.298
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-0.893	-0.332	3.695	2.139	0.691	-0.556	-0.332	-0.556	-0.893	-0.556	-2.191
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	-1.699	0.285	-0.318	-0.318	0.285	-0.991	1.129	3.082	1.129	-0.991	-1.695
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-2.197	-0.556	-0.556	-0.556	0.272	-2.197	0.691	1.319	1.706	1.706	-0.553
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-0.930	-0.685	-0.493	-0.685	-0.493	-3.485	1.991	2.328	1.394	0.701	-0.680
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.892	0.736	-1.906	-1.316	-0.551	-1.316	-0.551	-1.316	0.278	1.926	3.716
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	-0.247	-1.571	-0.247	-1.035	-0.247	-0.416	-1.571	-1.035	0.362	2.275	3.819
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	1.190	-0.382	-2.322	-0.382	0.233	0.877	-0.977	-1.501	-0.977	0.877	2.906
WANG_HCP_PROSTATE_CANCER WANG_HCP_PROSTATE_CANCER	-1.979	-0.617	1.002	0.593	-1.143	-3.334	2.156	-0.301	1.249	-0.301	0.789
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-1.466	-0.600	-0.365	1.601	-0.365	-2.280	3.512	0.637	0.416	-0.365	-0.945
HUPER_BREAST_BASAL_VS_LUMINAL_UP HUPER_BREAST_BASAL_VS_LUMINAL_UP	-0.556	0.272	-0.556	-2.197	0.455	0.980	-2.197	-0.556	-0.332	2.616	1.325
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	1.945	-0.270	-0.790	-1.888	0.648	0.648	-1.074	-1.888	-0.270	-0.790	3.489
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-1.681	-0.442	0.269	-0.572	-0.914	-2.411	-1.386	1.484	2.226	1.714	1.281
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	-0.399	2.820	0.587	-1.536	-0.235	-0.399	-1.536	-1.536	-0.645	-0.235	2.830
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	-0.940	0.279	-0.678	0.279	-0.476	-4.026	-0.940	0.771	1.859	1.542	1.004
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	1.477	-0.336	0.749	-1.024	-1.024	0.749	-1.741	-1.741	0.269	-0.336	2.440
MMS_MOUSE_LYMPH_HIGH_4HRS_UP MMS_MOUSE_LYMPH_HIGH_4HRS_UP	-1.492	-0.828	-0.234	0.380	-0.453	-1.492	0.984	4.314	0.380	-0.234	-0.825
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-0.586	0.692	0.559	1.843	-1.373	-3.779	0.692	2.092	-0.264	0.341	-1.642
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-1.077	-1.077	0.426	1.447	1.190	-2.947	0.426	2.724	-0.598	-1.408	0.430
FURUKAWA_DUSP6_TARGETS_PCI35_DN FURUKAWA_DUSP6_TARGETS_PCI35_DN	-1.455	-1.012	-0.454	-1.012	-0.454	-1.455	0.936	1.223	2.742	1.911	-1.007
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-1.609	-0.388	-0.727	1.218	-1.254	-2.573	3.080	1.470	0.331	0.610	-0.533
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-0.786	-1.181	-0.315	-1.181	-0.786	-1.181	-0.508	-0.315	2.411	0.675	3.933
KRASNOSELSKAYA_ILF3_TARGETS_UP KRASNOSELSKAYA_ILF3_TARGETS_UP	-1.658	-0.958	-0.300	-0.958	-0.958	0.302	-0.549	-0.549	0.820	2.599	2.608
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.434	0.541	-1.606	-1.064	-0.434	2.676	-1.606	-0.260	-1.064	0.541	2.686
CHANDRAN_METASTASIS_TOP50_UP CHANDRAN_METASTASIS_TOP50_UP	-1.616	0.320	0.555	0.858	-0.283	-0.925	0.858	3.284	-0.525	-0.925	-1.612
ANDERSEN_LIVER_CANCER_KRT19_UP ANDERSEN_LIVER_CANCER_KRT19_UP	-1.409	-0.407	1.512	2.010	1.079	-1.409	0.716	0.216	-0.407	-1.409	-0.762
HAN_JNK_SINGALING_UP HAN_JNK_SINGALING_UP	-0.796	-0.796	-1.450	0.403	-1.450	-0.219	-0.796	2.478	-0.219	0.403	2.486
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.704	-0.704	-0.704	-0.704	-0.272	-0.704	-0.704	-0.272	1.821	1.821	1.826
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	3.050	-0.312	-0.443	-1.099	-0.613	-1.099	-1.432	-1.099	-0.443	0.735	3.463
RASHI_RESPONSE_TO_IONIZING_RADIATION_1 RASHI_RESPONSE_TO_IONIZING_RADIATION_1	-0.525	1.226	-0.525	-1.616	-1.616	-1.616	-0.283	0.555	1.226	0.555	1.662
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	1.029	-0.406	-0.406	-1.963	0.357	2.939	-2.862	-0.626	0.539	0.763	-0.403
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	-2.698	1.351	1.864	2.151	-0.275	-0.886	-1.429	-0.515	-1.429	0.923	-0.272
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	-1.741	-0.336	-0.599	1.477	-0.336	-0.599	2.987	1.083	0.269	-0.599	-1.736
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	1.151	1.900	-0.645	-2.363	-0.645	-1.006	0.379	-0.645	-0.399	-0.645	2.830
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-1.837	0.301	0.635	-0.399	-1.260	-3.061	0.944	0.396	1.765	2.555	-0.653
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	0.243	1.024	-1.171	-0.369	-0.369	-2.290	-0.820	-0.820	-0.559	1.638	3.769
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	-0.327	-1.091	-2.180	-0.327	-0.506	-0.506	-0.506	-0.753	0.850	0.850	5.108
MODY_HIPPOCAMPUS_PRENATAL MODY_HIPPOCAMPUS_PRENATAL	-1.824	0.239	0.998	0.998	-0.373	-1.824	0.430	1.798	0.998	-1.090	-1.086
SANA_RESPONSE_TO_IFNG_DN SANA_RESPONSE_TO_IFNG_DN	-1.933	-1.420	-0.731	1.943	0.267	-1.420	2.312	1.943	-0.505	0.267	-0.501
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	-0.512	-0.373	0.611	-0.373	-2.336	-2.336	-1.167	0.340	0.782	1.984	2.634
BROWNE_HCMV_INFECTION_6HR_DN BROWNE_HCMV_INFECTION_6HR_DN	-0.767	0.945	2.111	2.708	-2.715	-1.852	-0.337	-0.767	0.268	0.615	-0.589
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.923	0.292	0.517	-0.556	-2.170	-1.779	-0.556	-0.923	1.430	2.511	2.227
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	-1.424	1.592	-0.276	-0.986	-1.424	-2.035	0.499	-0.668	0.499	1.259	2.377
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.571	-1.571	-1.035	2.275	0.564	-0.668	0.564	1.844	0.814	-0.247	-1.566
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	-0.427	1.477	-0.911	0.679	-0.633	-3.402	-0.427	0.326	0.679	2.578	-0.906
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-2.197	-0.893	0.980	1.319	0.272	-2.197	0.455	2.139	-0.332	-0.332	-0.330
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-0.442	-2.034	-1.632	-0.320	1.051	-1.296	-0.784	2.375	2.375	0.852	-0.589
UEDA_PERIFERAL_CLOCK UEDA_PERIFERAL_CLOCK	-2.863	-0.662	-0.285	-0.385	0.423	-3.419	0.853	0.853	1.952	1.035	0.428
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-1.284	0.264	-0.341	2.878	-0.341	-1.284	1.719	0.509	0.264	-0.671	-1.281
ZWANG_EGF_INTERVAL_UP ZWANG_EGF_INTERVAL_UP	2.241	1.610	0.859	-1.285	0.496	1.333	-2.163	-0.720	-0.720	-1.676	-0.518
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-1.609	-0.273	-0.963	0.610	-1.254	-2.573	0.458	-0.273	3.080	1.470	0.616
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	-1.741	-0.599	2.987	1.477	-1.024	-1.741	0.269	0.269	0.476	-0.336	0.271
AMIT_SERUM_RESPONSE_120_MCF10A AMIT_SERUM_RESPONSE_120_MCF10A	-1.241	-0.835	-1.819	0.422	-1.241	-1.241	0.262	2.289	0.422	1.502	1.509
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-1.381	-0.373	0.687	1.405	-1.029	-3.145	0.896	1.702	1.136	-0.373	-1.023
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.783	-0.810	0.906	0.651	-0.329	-1.783	2.808	1.546	0.274	-0.527	-1.206
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	1.242	0.564	-0.791	-0.270	0.564	-0.993	-1.830	-1.508	-1.508	1.045	3.470
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	-1.439	-1.439	0.361	1.021	-0.867	-1.439	2.706	2.056	0.820	-1.125	-0.482
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	-1.122	1.325	-0.287	-0.738	-0.470	-0.738	0.315	-1.677	-0.738	0.498	4.706
MUNSHI_MULTIPLE_MYELOMA_UP MUNSHI_MULTIPLE_MYELOMA_UP	-1.612	-0.797	1.350	-1.144	-0.355	-1.612	2.046	2.046	0.396	-1.144	0.582
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-1.741	-1.024	-0.599	1.083	0.269	-1.024	1.928	1.928	-0.599	0.749	-1.020
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-0.751	-0.522	0.390	0.557	-1.448	-1.966	3.079	0.759	0.557	0.995	-1.958
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	1.126	-0.570	-3.012	-2.101	-0.436	0.485	-0.926	-0.436	1.333	1.333	1.816
MAHAJAN_RESPONSE_TO_IL1A_DN MAHAJAN_RESPONSE_TO_IL1A_DN	-0.647	0.519	-0.647	0.997	-1.999	-0.264	-0.961	4.412	0.737	-0.647	-0.956
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.390	-0.390	-0.606	-0.910	-1.332	-1.332	-1.332	0.372	1.062	2.119	3.020
SHEPARD_BMYB_TARGETS SHEPARD_BMYB_TARGETS	-0.775	-2.217	-1.117	0.265	-0.523	-0.775	0.598	1.724	1.724	2.096	-1.112
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	1.988	-0.711	-0.489	0.278	-1.392	-1.005	-1.901	0.278	-0.489	0.595	3.680
LIM_MAMMARY_LUMINAL_MATURE_DN LIM_MAMMARY_LUMINAL_MATURE_DN	1.052	-0.642	-0.642	-0.897	-0.642	-2.197	-1.650	0.816	0.301	2.681	1.625
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	-1.397	0.272	2.139	0.272	-0.556	-2.197	-0.893	2.616	-0.556	0.272	0.458
ZHAN_MULTIPLE_MYELOMA_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD2_UP	-0.451	0.848	2.001	0.571	-1.990	-1.225	-0.451	-0.755	-1.225	2.001	0.354
BECKER_TAMOXIFEN_RESISTANCE_DN BECKER_TAMOXIFEN_RESISTANCE_DN	0.664	-0.578	-0.921	-0.921	-2.239	-0.348	0.258	2.076	-0.921	0.435	2.553
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.451	0.576	-1.540	-1.167	0.419	0.419	-2.009	-1.540	0.762	2.114	2.125
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	-0.935	0.678	0.678	1.371	-1.675	-4.436	0.826	0.333	0.333	-0.360	1.383
LIN_NPAS4_TARGETS_UP LIN_NPAS4_TARGETS_UP	-1.321	-0.845	0.853	1.695	-0.285	-4.073	0.853	1.456	0.690	-0.385	-0.655
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.489	-0.326	0.419	4.672	-1.005	-1.005	1.331	0.595	-1.005	-0.711	-1.385
IKEDA_MIR133_TARGETS_UP IKEDA_MIR133_TARGETS_UP	-1.824	-0.373	2.807	0.998	-0.373	-1.090	0.998	0.998	-1.090	-0.650	-0.647
CHOW_RASSF1_TARGETS_DN CHOW_RASSF1_TARGETS_DN	-1.243	-1.243	1.301	0.539	0.539	-1.243	1.796	0.283	0.539	-0.320	-1.240
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-2.280	-0.949	0.910	0.637	0.637	-1.466	0.910	-0.365	1.601	0.637	-1.461
GERHOLD_ADIPOGENESIS_UP GERHOLD_ADIPOGENESIS_UP	-0.256	-0.755	-0.256	4.205	-1.225	-1.225	-0.451	-0.451	0.848	1.180	-1.221
LU_AGING_BRAIN_DN LU_AGING_BRAIN_DN	0.500	0.275	-0.447	-0.594	0.275	-3.494	3.214	1.947	-0.447	-0.447	-0.986
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.958	0.451	2.468	1.112	-0.301	-2.510	0.451	1.112	-0.958	0.301	-1.828
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-1.824	-0.373	0.998	4.009	0.430	-0.373	-0.650	0.684	-0.650	-0.650	-1.086
DELPUECH_FOXO3_TARGETS_DN DELPUECH_FOXO3_TARGETS_DN	-0.958	-0.549	-0.958	0.302	-0.958	-1.658	1.594	1.176	2.599	0.302	-0.546
EPPERT_PROGENITOR EPPERT_PROGENITOR	-1.953	-0.553	1.351	1.120	0.426	-2.994	0.426	1.605	0.565	0.426	-1.550
MA_MYELOID_DIFFERENTIATION_UP MA_MYELOID_DIFFERENTIATION_UP	0.584	-1.575	-0.266	0.339	-1.575	-0.500	1.278	1.721	-0.266	0.898	-1.570
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.707	0.353	0.965	0.724	-0.865	-1.707	1.243	1.555	-0.255	0.724	-2.355
FERNANDEZ_BOUND_BY_MYC FERNANDEZ_BOUND_BY_MYC	-3.162	-0.491	0.551	1.663	-0.806	-2.229	0.691	2.177	0.551	-0.278	-0.274
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-1.424	0.328	1.592	2.366	-0.438	-2.035	0.966	0.499	0.328	-1.424	-0.981
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	-1.259	-0.782	-0.271	1.137	-2.031	-0.782	0.814	0.814	1.512	1.137	-1.255
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-1.771	-1.771	0.326	2.179	-0.278	-0.911	1.477	1.176	0.909	-0.633	-1.274
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-2.466	-1.074	-0.790	0.849	-0.270	-2.466	1.629	0.849	0.849	1.080	0.338
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	-0.278	0.326	-0.427	-1.771	0.326	-1.280	-1.771	0.484	1.176	-0.427	3.971
AMIT_EGF_RESPONSE_40_HELA AMIT_EGF_RESPONSE_40_HELA	-1.024	-1.741	0.476	-0.336	0.269	-1.741	-0.599	-0.336	1.477	1.928	1.088
BENPORATH_ES_CORE_NINE_CORRELATED BENPORATH_ES_CORE_NINE_CORRELATED	-1.798	-0.360	1.164	0.371	-0.733	-2.365	0.707	2.429	1.438	-0.733	-0.728
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-1.460	-0.810	0.323	-0.810	-0.810	-1.918	-0.280	0.629	1.905	3.413	0.326
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	0.404	-1.933	0.404	-0.731	1.604	1.943	-1.029	-1.933	0.267	-0.731	1.613
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	-0.911	0.490	-0.911	2.594	-0.406	-0.911	0.873	1.356	-0.406	-0.406	-0.909
BURTON_ADIPOGENESIS_12 BURTON_ADIPOGENESIS_12	-0.702	-0.702	-0.363	0.247	-0.702	-1.326	3.426	1.647	0.793	-0.702	-0.699
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-1.990	0.351	-0.256	0.351	-0.755	-1.990	0.848	0.571	2.485	-0.755	0.574
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	0.559	-0.323	-0.889	-0.889	-0.323	-0.651	-2.040	-1.190	3.604	1.752	0.564
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	-1.658	0.302	2.069	1.594	-0.958	-1.658	-0.300	-0.549	0.820	0.527	-0.546
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	-1.362	0.286	0.476	3.220	0.286	-1.362	-0.535	2.203	-0.865	-0.535	-0.861
HUTTMANN_B_CLL_POOR_SURVIVAL_DN HUTTMANN_B_CLL_POOR_SURVIVAL_DN	-0.691	5.545	0.784	0.346	-0.434	-0.691	-0.691	-1.606	-0.260	-0.260	-0.687
BILANGES_SERUM_RESPONSE_TRANSLATION BILANGES_SERUM_RESPONSE_TRANSLATION	-0.765	0.216	1.512	2.571	1.079	-0.407	-1.409	-1.409	0.216	-0.407	-0.762
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-1.326	0.793	-1.326	0.793	-1.326	-1.326	0.247	1.184	0.480	0.480	0.797
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	0.684	-0.241	-1.077	-0.520	-0.241	5.139	-1.077	-0.520	-0.241	-0.520	-0.239
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-2.197	-0.556	0.691	2.139	-0.893	-1.397	0.455	1.319	0.980	-0.556	-0.553
BURTON_ADIPOGENESIS_PEAK_AT_24HR BURTON_ADIPOGENESIS_PEAK_AT_24HR	-1.158	-1.158	-0.411	-0.228	-1.907	-0.411	1.271	0.625	2.640	0.920	-0.699
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	3.203	-0.326	-1.005	-1.005	0.806	0.595	-1.005	-1.392	-1.392	0.278	1.653
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	-1.214	-1.214	1.715	0.270	0.270	-2.071	-0.668	1.426	2.031	0.721	-1.207
DORN_ADENOVIRUS_INFECTION_12HR_DN DORN_ADENOVIRUS_INFECTION_12HR_DN	-1.367	-0.385	-1.367	-0.385	0.231	-1.367	0.754	0.453	2.092	1.577	-0.383
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	0.966	-0.438	-0.438	-0.986	-0.276	3.786	-0.986	-1.424	-1.424	0.328	1.266
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-3.090	0.386	0.766	0.766	-1.549	-2.624	0.496	1.104	0.926	0.496	0.773
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-1.234	-0.581	-0.436	0.388	-0.975	-3.460	0.513	0.827	1.979	1.979	0.287
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-0.771	-0.771	-0.771	-0.771	0.492	-3.183	0.667	0.346	1.108	3.109	0.350
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	0.898	-0.266	-1.575	-1.575	0.339	2.222	-0.500	-0.893	-0.500	1.721	-0.265
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3 GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	-0.580	-0.199	-0.580	-0.580	-0.580	-0.580	-0.580	-0.199	0.892	4.008	0.435
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	-0.614	1.516	-0.412	1.516	-0.614	-3.360	-0.614	0.339	-0.888	1.209	0.706
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	-0.714	-0.714	1.472	0.946	-0.984	-3.070	2.867	0.384	-0.348	-0.348	-0.345
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-1.023	-0.301	0.563	0.420	-2.130	-2.130	-0.424	0.420	0.923	3.708	-0.298
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	-1.243	-0.320	-1.243	-1.243	0.283	-0.320	-0.640	0.539	0.880	0.539	3.000
DIRMEIER_LMP1_RESPONSE_LATE_UP DIRMEIER_LMP1_RESPONSE_LATE_UP	-1.501	-0.622	0.397	0.612	-0.382	-1.501	0.877	0.612	-0.382	3.425	-1.496
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-2.043	-0.727	0.610	1.218	0.331	-2.573	2.045	1.470	0.331	-0.538	-0.721
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	2.343	0.768	-0.570	-0.926	0.276	-1.424	-0.327	-2.523	-0.926	1.333	1.571
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-1.393	-1.393	0.342	1.636	-0.961	-0.961	-0.422	2.872	0.737	-0.961	0.742
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	0.403	1.449	-0.796	-1.450	-0.796	-0.430	-0.430	-1.450	0.403	0.680	2.486
LANG_MYB_FAMILY_TARGETS LANG_MYB_FAMILY_TARGETS	-1.202	-1.202	-0.300	0.928	0.928	-1.202	0.302	0.928	1.365	0.302	-1.198
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-0.888	0.339	-0.412	2.230	-0.412	-3.360	0.701	0.502	0.701	0.701	-1.247
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.452	0.945	2.111	-0.594	-1.512	-2.715	-0.767	0.480	-0.452	2.401	0.271
GUTIERREZ_MULTIPLE_MYELOMA_UP GUTIERREZ_MULTIPLE_MYELOMA_UP	-1.492	-0.828	-0.453	0.646	-0.828	-1.492	2.977	0.646	0.380	0.646	-0.233
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	-1.432	-0.312	-0.312	2.676	-0.829	-2.982	1.163	-0.613	-0.312	0.936	0.741
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	0.632	-0.290	0.312	0.632	-1.621	-1.621	-2.164	-0.432	0.840	0.312	3.164
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	-1.575	-1.575	0.898	2.222	-0.500	-0.500	-0.893	0.339	0.898	0.898	-0.498
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	-1.832	0.310	-0.712	0.708	-1.832	-1.832	-0.292	1.081	1.300	0.310	2.396
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-1.090	-0.650	-0.650	0.239	-0.373	-1.824	0.239	3.385	0.998	0.998	-0.647
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-0.483	-0.661	-0.885	-0.343	-1.164	-2.445	2.201	2.540	0.870	0.515	-0.478
CHEN_PDGF_TARGETS CHEN_PDGF_TARGETS	-0.746	-0.298	-0.746	-0.746	-0.298	-0.746	-0.746	1.713	0.655	2.399	0.305
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-2.034	0.283	0.676	1.272	-0.442	-2.515	2.703	-0.442	0.391	0.676	-1.008
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	0.426	-0.462	-0.204	-0.994	-0.462	-0.994	-0.994	0.426	-0.462	0.772	3.822
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	-1.160	-0.280	0.324	-1.160	-0.580	-0.580	-0.580	-0.280	-0.280	2.564	2.572
VALK_AML_WITH_11Q23_REARRANGED VALK_AML_WITH_11Q23_REARRANGED	-0.462	2.357	0.426	-0.204	-0.462	-0.994	-0.204	2.357	-0.462	-0.994	-0.991
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-1.999	-0.538	-0.364	1.528	0.246	-2.696	0.539	1.856	0.967	0.376	-0.766
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	1.423	-0.354	-0.354	-1.782	-0.624	1.040	-1.782	-0.624	1.423	-0.354	1.044
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.120	-0.456	0.914	1.661	0.716	-3.829	1.387	0.281	0.400	-0.456	-0.842
LY_AGING_MIDDLE_DN LY_AGING_MIDDLE_DN	-0.663	-0.663	-0.247	-0.663	-0.247	-0.663	-0.663	1.292	3.556	0.362	-0.246
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	-0.462	-0.204	-0.994	0.772	-0.994	-0.994	0.426	1.213	2.357	-0.204	-0.991
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	-0.640	-0.640	0.283	-0.320	-1.243	-0.640	0.880	1.301	2.991	-1.243	-0.319
BURTON_ADIPOGENESIS_PEAK_AT_0HR BURTON_ADIPOGENESIS_PEAK_AT_0HR	-1.181	0.675	0.288	-0.786	-0.786	-1.748	0.459	-1.181	0.288	2.878	1.600
HENDRICKS_SMARCA4_TARGETS_UP HENDRICKS_SMARCA4_TARGETS_UP	-0.921	1.274	-0.921	0.435	-2.239	-0.921	-0.348	-0.578	0.435	2.076	1.280
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	-1.424	-0.668	0.328	0.966	0.499	-2.945	0.712	0.499	1.961	0.328	-0.981
FARMER_BREAST_CANCER_CLUSTER_1 FARMER_BREAST_CANCER_CLUSTER_1	0.848	0.571	-0.755	-1.990	0.351	-0.256	-1.990	-0.755	0.351	1.180	1.572
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	0.331	-0.538	-1.609	-0.388	-0.727	-1.609	-0.963	-0.388	1.470	1.470	3.096
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	-2.446	1.411	0.541	-0.691	-1.064	-1.064	-0.260	2.213	-0.434	0.784	0.348
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	-0.558	0.785	0.632	0.957	-1.714	-3.548	-0.558	0.497	1.585	1.148	-0.711
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	-0.301	2.892	-0.301	0.301	-0.849	-1.514	-1.143	-1.143	-0.438	0.301	2.906
KANNAN_TP53_TARGETS_DN KANNAN_TP53_TARGETS_DN	-0.911	-0.911	0.490	2.594	1.356	-0.911	-0.911	0.217	-0.406	-0.406	0.493
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	-0.911	-0.406	-0.911	0.217	-0.911	-0.911	0.490	0.873	3.338	0.217	0.218
CASTELLANO_NRAS_TARGETS_UP CASTELLANO_NRAS_TARGETS_UP	-0.689	-0.454	-1.012	0.481	-2.071	-1.012	-0.454	-0.454	1.223	1.911	2.320
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	-1.990	-0.256	-0.451	0.848	-0.755	-1.990	1.565	0.571	-0.451	0.571	1.185
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.459	0.643	-0.817	-3.159	-1.054	-0.623	-0.623	-0.465	0.495	1.222	2.010
MARTIN_VIRAL_GPCR_SIGNALING_UP MARTIN_VIRAL_GPCR_SIGNALING_UP	0.404	-0.505	-0.731	-0.505	-0.338	-0.338	-3.610	0.782	-0.338	1.604	1.953
AMIT_EGF_RESPONSE_120_MCF10A AMIT_EGF_RESPONSE_120_MCF10A	-0.991	-0.574	-0.991	1.129	-1.699	-0.991	-0.574	0.783	0.783	1.129	1.540
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-1.035	-0.668	1.456	0.564	-1.035	-2.405	0.814	0.814	0.814	0.814	-1.030
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.911	-0.911	-0.911	0.490	0.490	-0.911	0.490	0.873	1.932	0.490	-0.909
GAVIN_FOXP3_TARGETS_CLUSTER_T4 GAVIN_FOXP3_TARGETS_CLUSTER_T4	-2.264	1.255	-0.678	1.255	-0.476	-2.994	0.412	0.771	0.771	-0.324	0.580
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	-0.828	-0.351	0.566	0.566	0.991	-0.828	2.148	0.566	-0.828	-0.828	-0.826
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	-2.734	0.881	1.091	0.881	-1.063	-1.369	-0.321	2.494	0.282	0.282	-0.807
KESHELAVA_MULTIPLE_DRUG_RESISTANCE KESHELAVA_MULTIPLE_DRUG_RESISTANCE	-1.803	-0.652	0.657	3.880	-0.934	-0.652	-0.934	1.144	-0.442	0.657	-0.439
RODRIGUES_THYROID_CARCINOMA_UP RODRIGUES_THYROID_CARCINOMA_UP	-0.663	-0.247	1.939	2.696	-0.247	-0.663	0.362	-0.663	-0.663	-0.663	-0.246
LEE_METASTASIS_AND_RNA_PROCESSING_UP LEE_METASTASIS_AND_RNA_PROCESSING_UP	-0.663	-0.247	-0.247	2.696	0.362	-0.663	1.939	-0.663	-0.663	-0.247	-0.661
SMIRNOV_RESPONSE_TO_IR_2HR_UP SMIRNOV_RESPONSE_TO_IR_2HR_UP	-2.197	0.272	-0.556	-0.556	-0.893	-0.893	-0.332	0.272	1.706	2.616	0.695
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.289	0.313	-1.308	-0.289	-0.934	-1.803	-0.289	-0.442	1.144	4.390	-0.287
GNATENKO_PLATELET_SIGNATURE GNATENKO_PLATELET_SIGNATURE	-0.650	-1.824	0.684	0.239	-0.373	-0.373	1.798	2.277	0.430	-1.090	-1.086
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	1.899	0.390	-1.053	-1.966	-0.351	-1.053	-0.351	-0.351	-0.522	3.529	0.259
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	1.055	-0.355	-1.612	-2.253	-1.144	-0.541	0.253	0.253	1.055	2.455
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	0.823	-0.621	-0.621	-0.621	-0.621	-0.621	-0.621	-0.223	0.396	0.823	2.871
DAIRKEE_CANCER_PRONE_RESPONSE_BPA DAIRKEE_CANCER_PRONE_RESPONSE_BPA	-1.328	0.301	0.301	2.767	0.750	-2.114	-0.301	0.750	0.301	-0.301	-1.323
FLORIO_HUMAN_NEOCORTEX FLORIO_HUMAN_NEOCORTEX	0.625	1.677	-0.702	-0.702	0.625	-0.228	-1.158	-1.907	-1.158	0.920	1.277
KAYO_AGING_MUSCLE_DN KAYO_AGING_MUSCLE_DN	-1.609	-2.043	1.218	3.080	-0.538	-1.254	0.610	0.610	0.458	-0.273	-0.533
RAHMAN_TP53_TARGETS_PHOSPHORYLATED RAHMAN_TP53_TARGETS_PHOSPHORYLATED	-0.351	-0.828	-0.828	0.256	-0.828	-0.351	3.671	0.566	0.566	0.256	-0.826
LIU_CMYB_TARGETS_UP LIU_CMYB_TARGETS_UP	-1.201	-0.328	-0.752	0.787	-1.201	-2.224	1.615	1.615	0.276	1.870	-0.745
FARDIN_HYPOXIA_11 FARDIN_HYPOXIA_11	-0.363	-1.326	0.480	-0.702	-1.326	-1.326	0.480	0.793	1.184	1.647	0.248
QI_HYPOXIA QI_HYPOXIA	-1.792	-0.342	1.271	0.840	-0.849	-2.798	-0.849	0.264	1.044	1.522	0.666
PRAMOONJAGO_SOX4_TARGETS_DN PRAMOONJAGO_SOX4_TARGETS_DN	-2.031	-0.472	0.546	1.938	-0.271	-2.031	0.546	0.546	0.334	0.814	-0.779
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-1.090	0.239	1.370	0.998	0.430	-1.090	1.798	0.430	-0.373	-1.090	-1.819
JACKSON_DNMT1_TARGETS_UP JACKSON_DNMT1_TARGETS_UP	-1.280	-1.280	-0.911	-0.427	-0.633	-1.771	0.909	1.812	0.679	1.812	0.683
UROSEVIC_RESPONSE_TO_IMIQUIMOD UROSEVIC_RESPONSE_TO_IMIQUIMOD	-0.324	-0.787	-0.787	-0.324	-0.324	-0.787	-0.787	-0.324	2.269	1.613	1.060
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	-2.510	-0.958	0.301	1.402	-1.336	-0.958	1.726	1.402	0.451	-0.301	0.304
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	-0.393	-0.393	-0.552	-1.334	0.467	0.816	-2.225	-0.756	1.032	-0.393	3.692
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-1.803	-0.652	-0.289	0.467	-0.652	-2.473	-0.442	2.130	0.657	1.439	0.661
MARZEC_IL2_SIGNALING_UP MARZEC_IL2_SIGNALING_UP	-0.418	-1.383	-1.787	0.593	0.439	-1.787	-0.418	3.559	0.775	0.439	0.314
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	-1.241	0.876	-1.241	1.168	-0.344	-2.696	0.627	1.168	0.876	0.262	-0.543
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	-0.784	0.522	0.391	0.676	-1.296	-3.093	-1.296	0.283	1.051	1.516	1.282
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-0.578	0.258	-0.578	3.053	-1.431	-1.431	-0.348	0.944	1.652	-0.578	-0.575
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	-1.328	-2.114	-0.513	1.412	-0.301	-0.837	2.270	0.750	0.498	-0.513	0.304
ROSS_AML_OF_FAB_M7_TYPE ROSS_AML_OF_FAB_M7_TYPE	0.342	-0.264	-1.393	0.342	-0.961	-2.903	1.297	-0.264	0.997	1.636	-0.261
KYNG_DNA_DAMAGE_DN KYNG_DNA_DAMAGE_DN	-0.821	-0.285	0.538	-0.821	-1.877	-1.269	1.198	0.832	1.408	2.145	-1.540
GAVIN_FOXP3_TARGETS_CLUSTER_P4 GAVIN_FOXP3_TARGETS_CLUSTER_P4	-0.752	1.702	-0.537	-1.029	-0.537	-1.381	-0.373	-1.381	2.760	0.359	1.413
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	-1.077	-1.077	1.578	-1.077	0.371	-1.077	1.088	1.088	-0.241	-0.241	0.373
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	-0.574	-0.318	-0.574	-0.574	-1.699	-1.699	0.783	1.534	0.285	1.534	0.787
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-2.414	1.357	0.891	1.357	-0.866	-2.414	-0.645	0.388	0.697	0.697	-0.329
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-1.901	0.345	0.345	-0.475	-0.798	-2.774	0.907	0.345	0.738	2.951	0.349
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-1.431	-0.578	0.664	0.944	0.435	-1.431	0.258	1.652	0.664	0.435	-2.233
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	-0.488	-1.064	-0.488	-0.732	-1.517	-1.064	0.288	0.288	0.445	3.071	2.210
ZHANG_BREAST_CANCER_PROGENITORS_DN ZHANG_BREAST_CANCER_PROGENITORS_DN	-1.535	-0.719	-0.396	1.914	-0.283	-2.962	1.914	-0.539	0.580	0.320	0.751
HINATA_NFKB_TARGETS_KERATINOCYTE_UP HINATA_NFKB_TARGETS_KERATINOCYTE_UP	0.289	-0.691	0.289	-1.868	-0.473	-0.981	0.435	-0.691	-0.691	2.034	3.281
BARIS_THYROID_CANCER_UP BARIS_THYROID_CANCER_UP	-0.994	-0.462	0.426	-0.204	-0.462	-0.462	1.213	3.813	-0.462	-0.462	-0.991
ZHENG_IL22_SIGNALING_DN ZHENG_IL22_SIGNALING_DN	-0.574	-0.991	0.285	0.783	-1.699	0.501	-0.318	0.285	-0.318	-0.991	3.711
CHEOK_RESPONSE_TO_HD_MTX_DN CHEOK_RESPONSE_TO_HD_MTX_DN	-0.406	0.217	0.490	-0.911	-0.406	-0.911	1.356	1.932	0.873	-0.911	-0.909
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	-0.351	0.256	-0.828	0.991	-0.351	-0.828	2.148	1.521	-0.351	-0.828	-0.826
FRIDMAN_SENESCENCE_UP FRIDMAN_SENESCENCE_UP	-2.253	0.253	0.396	-0.541	0.253	-1.612	-1.144	0.798	0.253	2.046	1.689
AMIT_SERUM_RESPONSE_60_MCF10A AMIT_SERUM_RESPONSE_60_MCF10A	-0.668	-0.247	-0.416	-0.247	-1.571	-1.571	-0.668	-0.416	1.844	0.814	2.757
TAVOR_CEBPA_TARGETS_DN TAVOR_CEBPA_TARGETS_DN	-1.326	0.247	0.247	-0.702	-1.326	-0.702	0.247	-0.702	1.647	1.184	1.652
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	-1.918	-0.585	1.053	0.461	-0.280	-3.258	1.309	-0.411	1.309	0.461	0.326
VERHAAK_GLIOBLASTOMA_CLASSICAL VERHAAK_GLIOBLASTOMA_CLASSICAL	-0.518	0.428	0.428	1.278	-2.091	-2.091	-0.872	-0.678	0.557	2.625	0.713
GILDEA_METASTASIS GILDEA_METASTASIS	-1.202	-0.300	0.302	0.572	-1.202	-0.300	-0.300	-1.202	-0.300	1.365	2.467
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	0.801	2.412	-1.118	-0.704	-0.310	-0.704	-3.516	-0.310	0.646	0.976	0.515
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-1.362	0.522	0.995	3.768	-0.689	-1.669	0.660	-0.533	0.402	-0.301	-1.352
SU_PLACENTA SU_PLACENTA	-1.284	-0.341	0.264	-0.671	-0.341	0.509	-1.284	0.509	0.509	-0.671	3.562
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	-0.870	1.436	-0.870	-0.870	1.436	-0.378	-0.870	-0.378	-0.378	0.930	0.933
LANDIS_ERBB2_BREAST_TUMORS_324_UP LANDIS_ERBB2_BREAST_TUMORS_324_UP	-2.821	0.399	0.399	-0.567	-1.214	-1.214	0.845	2.621	1.037	0.526	-0.420
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.944	1.124	-0.659	-1.528	-1.528	-1.028	-1.528	0.301	1.535	0.396	2.027
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-0.775	-0.775	-0.341	0.412	-0.341	-1.580	0.598	1.724	2.096	0.598	-2.209
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	4.598	-0.765	0.216	-0.407	-0.407	0.716	-0.765	-1.409	-0.407	0.216	0.217
URS_ADIPOCYTE_DIFFERENTIATION_DN URS_ADIPOCYTE_DIFFERENTIATION_DN	-0.671	-0.671	0.264	0.264	-1.284	0.264	0.836	-0.341	0.264	-1.284	3.562
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.536	0.872	0.291	0.291	-2.007	-1.274	-1.274	-0.580	-0.767	2.103	2.116
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	1.416	0.818	-0.885	-1.891	0.581	1.416	-1.302	-1.302	0.238	-0.586	1.102
GAZIN_EPIGENETIC_SILENCING_BY_KRAS GAZIN_EPIGENETIC_SILENCING_BY_KRAS	-0.491	-0.491	0.398	1.149	-1.036	-1.036	-1.036	2.916	-0.222	0.398	-0.221
STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS	-0.456	-0.456	3.761	-0.456	-0.456	-0.456	0.187	0.578	0.578	-0.456	-0.454
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	0.386	0.496	0.293	1.510	-0.672	-4.947	-0.310	-0.310	0.766	1.104	-0.522
BENPORATH_NOS_TARGETS BENPORATH_NOS_TARGETS	-0.993	-0.791	-0.363	1.690	-0.993	-2.634	1.941	1.045	-0.363	-0.479	1.054
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP	-0.817	-0.623	0.643	-0.817	-1.340	-2.576	1.222	1.007	0.265	2.298	0.500
LINDSTEDT_DENDRITIC_CELL_MATURATION_B LINDSTEDT_DENDRITIC_CELL_MATURATION_B	0.334	-0.472	0.546	0.334	-1.259	-2.031	0.814	-1.259	1.512	1.512	-0.469
YANG_BREAST_CANCER_ESR1_LASER_DN YANG_BREAST_CANCER_ESR1_LASER_DN	-0.755	-0.755	-0.256	0.351	0.351	-1.225	0.848	2.001	1.565	-0.451	-1.984
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	1.082	-0.691	-0.473	-0.473	-0.981	0.289	-0.981	-1.868	-0.313	2.034	2.427
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-2.071	0.481	-0.288	0.481	-2.071	-1.455	0.481	1.223	0.936	1.223	-0.286
CROMER_METASTASIS_UP CROMER_METASTASIS_UP	-1.486	-0.471	0.906	2.680	-0.301	-1.038	-0.301	1.863	0.301	-1.038	-1.033
BIDUS_METASTASIS_DN BIDUS_METASTASIS_DN	-2.397	0.266	0.266	-0.791	0.487	-2.397	1.649	0.791	1.178	0.974	-0.602
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-1.707	0.965	-0.255	1.243	-0.596	-1.707	0.724	0.965	-0.397	1.243	-1.700
TSAI_RESPONSE_TO_IONIZING_RADIATION TSAI_RESPONSE_TO_IONIZING_RADIATION	-1.193	-0.301	-0.939	-0.413	-0.728	-1.858	0.301	-0.413	3.353	0.864	1.522
AMIT_EGF_RESPONSE_240_MCF10A AMIT_EGF_RESPONSE_240_MCF10A	-0.870	-0.378	0.527	-0.378	-0.870	-0.870	-0.870	0.527	2.725	0.527	0.529
GUO_TARGETS_OF_IRS1_AND_IRS2 GUO_TARGETS_OF_IRS1_AND_IRS2	-0.918	1.024	-1.252	2.628	1.024	-2.231	-0.313	0.290	-0.313	0.594	-0.913
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	0.536	-0.430	-0.580	-2.485	0.693	0.872	-0.996	-0.996	-0.767	1.298	2.428
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-1.925	1.361	-0.402	0.647	-1.594	-2.307	0.647	-0.402	1.361	0.968	0.520
ELVIDGE_HYPOXIA_BY_DMOG_DN ELVIDGE_HYPOXIA_BY_DMOG_DN	-2.446	0.541	-0.434	0.784	-1.064	-1.064	0.541	2.213	0.784	-0.260	-0.431
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	0.519	-0.264	-0.264	-1.999	-1.393	-1.393	0.519	-0.647	2.012	0.737	1.304
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.331	-0.625	-0.461	0.518	-2.766	-0.831	-0.625	-0.625	2.130	1.553	1.307
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	0.930	0.930	-0.378	-0.870	0.527	-0.870	-0.870	-0.870	-0.378	2.036	0.237
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	0.355	-0.522	0.859	-0.253	-1.285	-2.774	0.496	-0.720	1.333	2.241	-0.518
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	-0.792	0.593	0.439	-0.291	-2.913	-1.787	-0.291	1.218	-0.291	0.775	1.776
JIANG_HYPOXIA_VIA_VHL JIANG_HYPOXIA_VIA_VHL	-0.787	-0.324	1.057	1.057	-0.787	-0.787	0.609	1.057	0.609	-0.787	-0.785
LI_INDUCED_T_TO_NATURAL_KILLER_DN LI_INDUCED_T_TO_NATURAL_KILLER_DN	-1.926	0.438	0.745	1.144	-1.209	-1.535	2.536	0.320	-0.283	0.580	-0.933
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	-0.312	-0.451	-0.312	2.114	-0.312	-1.167	2.464	-2.009	0.290	-1.167	0.581
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-0.647	0.309	2.042	1.792	-0.647	-3.561	-0.389	-0.647	0.519	0.519	-0.290
KIM_MYCN_AMPLIFICATION_TARGETS_DN KIM_MYCN_AMPLIFICATION_TARGETS_DN	-0.869	2.114	2.114	-0.451	-0.869	-2.603	0.290	-0.451	0.576	-0.451	0.423
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	-0.497	0.166	0.166	-0.497	0.166	-0.497	-0.497	-0.497	1.731	-0.497	2.552
SASAKI_TARGETS_OF_TP73_AND_TP63 SASAKI_TARGETS_OF_TP73_AND_TP63	0.166	-0.497	0.166	-0.497	-0.497	-0.497	-0.497	2.547	-0.497	1.731	0.167
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	1.246	1.007	0.322	-0.774	-2.256	-1.034	-1.034	0.452	-0.281	-0.405	2.469
